Shenghong Gu

Introduction to the Chinese Space Station Survey Telescope (CSST)

Yan Gong, Haitao Miao, Hu Zhan et al. · Science China Physics Mechanics and Astronomy · 2026 · 36 citations · Full text

Natural Sciences, Aerospace Engineering, Astronomy +12

Efficacy and safety benefits of <scp>iGlarLixi</scp> versus insulin glargine 100 U/ <scp>mL</scp> or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents: The <scp>LixiLan‐O‐AP</scp> randomized controlled trial

Wenying Yang, Xiaolin Dong, Qingju Li et al. · Diabetes Obesity and Metabolism · 2022 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Improved glycaemic control and weight benefit with <scp>iGlarLixi</scp> versus insulin glargine 100 U/ <scp>mL</scp> in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the <scp>LixiLan‐L‐CN</scp> randomized controlled trial

Xiaoyong Yuan, Xiaohui Guo, Junqing Zhang et al. · Diabetes Obesity and Metabolism · 2022 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17